+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies



Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies



Hypertension 54(5): 1084-1091



Blood pressure-lowering therapy reduces left ventricular mass, but the question of whether differences exist among drug classes has not been fully resolved. Our aim was to compare the effects of diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers on left ventricular mass regression in patients with hypertension on the basis of prospective, randomized comparative studies. We performed meta-analyses, involving pooled pairwise comparisons of the drug classes and of each class versus other classes statistically combined, and meta-regression analyses to identify the determinants of the regression. The 75 relevant publications involved 84 pairwise comparisons and 6001 patients. Regression of left ventricular mass was significantly less (P=0.01) with beta-blockers (9.8%) than with angiotensin receptor blockers (12.5%), but none of the other analyzable pairwise comparisons between drug classes revealed significant differences (P>0.10). In addition, beta-blockers showed less regression than the other 4 classes statistically combined (P<0.01), and regression was more pronounced with angiotensin receptor blockers versus the others (P<0.01). In multivariable meta-regression analysis on all of the treatment arms, beta-blocker treatment was a significant and negative predictor of the regression (-3.6%; P<0.01), but this was not the case for the other drug classes, including angiotensin receptor blockers. In conclusion, beta-blockers show less regression of left ventricular mass, whereas angiotensin receptor blockers may induce larger regression. The inferiority of beta-blockers appears to be more convincing than the superiority of angiotensin receptor blockers.

(PDF emailed within 0-6 h: $19.90)

Accession: 055446930

Download citation: RISBibTeXText

PMID: 19770405

DOI: 10.1161/HYPERTENSIONAHA.109.136655


Related references

Blood pressure-independent effects of telmisartan on regression of left ventricular mass: a meta-analysis and meta-regression of randomized controlled trials. International Journal of Cardiology 165(3): 564-567, 2014

Meta-analysis suggests regression of left ventricular hypertrophy during antihypertensive treatment is linked to reduced risk of cardiovascular disease. Evidence-Based Cardiovascular Medicine 8(1): 22-3; Discussion 24-5, 2005

Reduction of left ventricular hypertrophy by antihypertensive therapy Results of a meta-analysis of all double-blind randomized studies. Journal of the American College of Cardiology 37(2 Supplement A): 261A-262A, February, 2001

Comparative evaluation of left ventricular mass regression after aortic valve replacement: a prospective randomized analysis. Journal of Cardiothoracic Surgery 6(): 136-136, 2012

Left ventricular mass regression in the LIFE study: Effect of previous antihypertensive treatment. American Journal of Hypertension 16(3): 180-186, March, 2003

Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol. American Heart Journal 117(1): 145-150, 1989

The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. Journal of Hypertension 13(8): 823-829, 1995

Long-term antihypertensive treatment may induce normalization of left ventricular mass before complete regression of vascular structural changes. Journal of Hypertension 6(4): S94-96, 1988

Treatment of left ventricular hypertrophy Meta-analysis of all randomized double-blind studies until January 2000. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 485A, September, 2001

Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy. Hypertension 63(2): 252-258, 2014

Left ventricular hypertrophy regression with angiotensin converting enzyme inhibitor antihypertensive treatment depends on the dipping status and left ventricular geometry pattern. American Journal of Hypertension 16(5 Part 2): 176A-177A, 2003

Meta-analysis. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrology Dialysis Transplantation 13(3): 564-569, 1998

Long-term antihypertensive treatment may induce normalization of left ventricular mass before complete regression of vascular structural changes: consequences for cardiac function at rest and during stress. Journal of Hypertension. Supplement 6(4): S94-S96, 1988

Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial. Circulation 104(11): 1248-1254, 2001

Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. Annals of Thoracic Surgery 84(1): 73-78, 2007